Abstract
Thirteen α-aminophosphonate derivatives with artesunate were synthesized by introducing bioactive α-aminophosphonate combination with artesunate in this work. The reaction were easily carried out at normal pressure, low temperature and without any catalyst. Four strains of microbials, namely Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida albicans, were used for the evaluation of the antimicrobial activities of these target compounds. Experimental results indicated that most of the compounds had good inhibitory effects. Compound 7k showed obvious antimicrobial activities with the MICs of 64 μg/ml against Staphylococcus aureus and 32 μg/ml against Candida albicans. Furthermore, when combined with roxithromycin, the synthesized compounds showed overlapping enhanced activities and proved potential antimicrobial synergists of roxithromycin.
Keywords: Artesunate, α-aminophosphonate, Antimicrobial Activity, Synthesis.
Letters in Drug Design & Discovery
Title:Synthesis of Derivatives of Artesunate α-Aminophosphonate and Their Antimicrobial Activities
Volume: 12 Issue: 5
Author(s): Sheng He, Xilin Ouyang, Xiaochao Huang, Weisong Hu, Weilong Dai, Xiaoyan Tian, Yingming Pan, Shiwen Huang and Hengshan Wang
Affiliation:
Keywords: Artesunate, α-aminophosphonate, Antimicrobial Activity, Synthesis.
Abstract: Thirteen α-aminophosphonate derivatives with artesunate were synthesized by introducing bioactive α-aminophosphonate combination with artesunate in this work. The reaction were easily carried out at normal pressure, low temperature and without any catalyst. Four strains of microbials, namely Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida albicans, were used for the evaluation of the antimicrobial activities of these target compounds. Experimental results indicated that most of the compounds had good inhibitory effects. Compound 7k showed obvious antimicrobial activities with the MICs of 64 μg/ml against Staphylococcus aureus and 32 μg/ml against Candida albicans. Furthermore, when combined with roxithromycin, the synthesized compounds showed overlapping enhanced activities and proved potential antimicrobial synergists of roxithromycin.
Export Options
About this article
Cite this article as:
He Sheng, Ouyang Xilin, Huang Xiaochao, Hu Weisong, Dai Weilong, Tian Xiaoyan, Pan Yingming, Huang Shiwen and Wang Hengshan, Synthesis of Derivatives of Artesunate α-Aminophosphonate and Their Antimicrobial Activities, Letters in Drug Design & Discovery 2015; 12 (5) . https://dx.doi.org/10.2174/1570180812666141125004502
DOI https://dx.doi.org/10.2174/1570180812666141125004502 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Polyhedric Abl Kinases and their Pharmacologic Inhibitors
Current Enzyme Inhibition Synthesis of Novel Test Compounds for Antiviral Chemotherapy of Severe Acute Respiratory Syndrome (SARS)
Current Medicinal Chemistry Identification and Characterization of the Binding Sites of P-Glycoprotein for Multidrug Resistance-Related Drugs and Modulators
Current Medicinal Chemistry - Anti-Cancer Agents The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Current Cancer Drug Targets Radioprotective and Anticancer Efficacies of Ganoderma Lucidum in a Mouse Tumor Model
Current Traditional Medicine Small Molecular Inhibitors of p-STAT3: Novel Agents for Treatment of Primary and Metastatic CNS Cancers
Recent Patents on CNS Drug Discovery (Discontinued) HIV-1 Infected Patients have Antibodies Recognizing Folded Tat
Infectious Disorders - Drug Targets Tumor-Targeting Peptides and Small Molecules as Anti-Cancer Agents to Overcome Drug Resistance
Current Medicinal Chemistry The mTOR Pathway: A New Target in Cancer Therapy
Current Cancer Drug Targets AZT: An Old Drug with New Perspectives
Current Clinical Pharmacology Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Current Cancer Drug Targets A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma
Current Topics in Medicinal Chemistry Effects of Antiretroviral Therapy on Immunity in Patients Infected with HIV
Current Pharmaceutical Design Novel Therapeutic Strategies for Dementia
CNS & Neurological Disorders - Drug Targets Paclitaxel Formulations: Challenges and Novel Delivery Options
Current Drug Delivery Hypoxia PET Tracers in EBRT Dose Planning in Head and Neck Cancer
Current Radiopharmaceuticals The Cell Wall-Associated Proteins in the Dimorphic Pathogenic Species of Paracoccidioides
Current Protein & Peptide Science Recent Anticancer Cytotoxic Agents
Current Medicinal Chemistry - Anti-Cancer Agents Inverse Regulation of MMP-9 and MMP-2 in Long-Term Follow-up After Acute Coronary Syndrome: Lack of Correlation with Platelet and Endothelial Cell Activation Markers
Vascular Disease Prevention (Discontinued) Anti-TNF Antibodies in Inflammatory Bowel Disease: Do We Finally Know How it Works?
Current Drug Targets